Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy with Metvix for genital lichen sclerosus and refractory anogenital dysplasia
2009-015640-42Phase 4Completed
- Start
- Sep 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methyl aminolevulinate in Kraurosis vulvae and anogenital dysplasia. Primary endpoint: Therapeutic efficacy of photodynamic therapy. Started Sep 2009; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
Kraurosis vulvaeanogenital dysplasia
Beyond the preview
Go deeper on 2009-015640-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015640-42.